ANGPTL6 and hepatocellular carcinoma: In addition, ANGPTL6 as a potential diagnosis and prognostic biomarker of HCC was evaluated in the above liver tissues and validated in the GEO database, another set of liver samples, and serum samples of 23 normal healthy controls and 42 HCC patients.